Phase I Trial of Oral 5-azacitidine With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Azacitidine (Primary) ; Romidepsin (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.